[144] Jazz Pharmaceuticals, Inc. SEC Filing
The filing is a Form 144 reporting a proposed sale of 3,731 shares of common stock with an aggregate market value of $417,872. The securities are listed as outstanding in the amount of 60,658,809 shares and the proposed sale is identified for 08/08/2025 on NASDAQ.
The shares were acquired on 08/07/2025 as restricted stock vesting from the issuer and the consideration is listed as compensation. The form notes "Nothing to Report" for securities sold during the past three months. Several filer contact fields (including CIK and submission contact details) appear blank in the provided content.
La comunicazione 猫 un Form 144 che segnala una proposta di vendita di 3,731 azioni ordinarie per un valore complessivo di $417,872. I titoli risultano in circolazione in quantit脿 di 60,658,809 azioni e la vendita proposta 猫 programmata per il 08/08/2025 sul NASDAQ.
Le azioni sono state acquisite il 08/07/2025 come restricted stock vesting dall'emittente e la contropartita 猫 indicata come compensation. Il modulo riporta "Nothing to Report" riguardo ai titoli venduti negli ultimi tre mesi. Diversi campi di contatto del dichiarante (inclusi CIK e dettagli di contatto per l'invio) risultano vuoti nel contenuto fornito.
La presentaci贸n es un Formulario 144 que informa una propuesta de venta de 3,731 acciones ordinarias por un valor agregado de $417,872. Los valores figuran como en circulaci贸n en la cantidad de 60,658,809 acciones y la venta propuesta est谩 programada para el 08/08/2025 en NASDAQ.
Las acciones se adquirieron el 08/07/2025 como restricted stock vesting del emisor y la contraprestaci贸n se registra como compensation. El formulario se帽ala "Nothing to Report" respecto a valores vendidos en los 煤ltimos tres meses. Varios campos de contacto del declarante (incluido el CIK y los detalles de contacto de la presentaci贸n) aparecen en blanco en el contenido proporcionado.
頃措嫻 鞝滌稖靹滊姅 鞝滌晥霅� 毵り皝鞚� 氤搓碃頃橂姅 Form 144搿�, 氤错喌欤� 3,731欤茧ゼ 齑濎暋 $417,872鞐� 毵り皝頃� 鞓堨爼鞛勳潉 旮办灛頃橁碃 鞛堨姷雼堧嫟. 歃濌秾鞚� 鞙犿喌 欤检嫕靾� 60,658,809欤茧 霌膘灛霅橃柎 鞛堨溂氅� 鞝滌晥霅� 毵り皝 鞚检瀽電� 08/08/2025, 瓯半灅靻岆姅 NASDAQ搿� 響滉赴霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 欤检嫕鞚� 氚滍枆靷攵�韯� 08/07/2025鞐� restricted stock vesting鞙茧 旆摑霅橃棃鞙茧┌ 雽�臧�電� compensation鞙茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞏戩嫕鞐愲姅 斓滉芳 3臧滌洈 霃欖晥 毵り皝霅� 歃濌秾鞐� 雽�頃� "Nothing to Report"搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞛� 鞐半澖觳� 頃勲摐(鞓�: CIK 氚� 鞝滌稖 鞐半澖觳� 靸侅劯)臧� 鞝滉车霅� 雮挫毄鞐愳劀 牍勳柎 鞛堧姅 頃鞚� 鞐煬 臧� 鞛堨姷雼堧嫟.
Le d茅p么t est un Formulaire 144 signalant une proposition de vente de 3,731 actions ordinaires pour une valeur globale de $417,872. Les titres sont inscrits comme en circulation 脿 hauteur de 60,658,809 actions et la vente propos茅e est pr茅vue pour le 08/08/2025 sur le NASDAQ.
Les actions ont 茅t茅 acquises le 08/07/2025 en tant que restricted stock vesting de l'茅metteur et la contrepartie est indiqu茅e comme compensation. Le formulaire note "Nothing to Report" concernant les titres vendus au cours des trois derniers mois. Plusieurs champs de contact du d茅clarant (y compris le CIK et les coordonn茅es de soumission) apparaissent vides dans le contenu fourni.
Die Einreichung ist ein Formular 144, das einen geplanten Verkauf von 3,731 Stammaktien mit einem Gesamtmarktwert von $417,872 meldet. Die Wertpapiere sind mit einer ausstehenden St眉ckzahl von 60,658,809 Aktien aufgef眉hrt, und der geplante Verkauf ist f眉r den 08/08/2025 an der NASDAQ angegeben.
Die Aktien wurden am 08/07/2025 als restricted stock vesting vom Emittenten erworben, und die Gegenleistung ist als compensation aufgef眉hrt. Das Formular vermerkt "Nothing to Report" f眉r in den letzten drei Monaten verkaufte Wertpapiere. Mehrere Kontaktfelder des Meldenden (einschlie脽lich CIK und Einreichungskontaktdaten) sind in den bereitgestellten Inhalten leer.
- Transaction is small relative to outstanding shares (3,731 of 60,658,809, 鈮�0.006%), implying limited market impact
- Securities were acquired as compensation via restricted stock vesting, a routine corporate compensation mechanism
- Planned sale occurs one day after vesting (acquired 08/07/2025; approximate sale 08/08/2025), which may attract attention to timing
- Filer identification and contact fields are blank in the provided content, a gap in the extracted filing information
Insights
TL;DR: A small, routine insider-related sale: 3,731 shares worth $417,872, representing roughly 0.006% of outstanding stock.
The transaction size is immaterial to market capitalization given 3,731 shares versus 60,658,809 outstanding (鈮�0.006%). The filing shows the shares were acquired via restricted stock vesting and are being sold the next day, producing $417,872 of aggregate value. No prior sales by the person are reported in the last three months. From a financial-impact perspective, this disclosure is routine and unlikely to move investor valuation.
TL;DR: Governance signals are routine but immediate post-vesting sale is notable for timing; disclosure appears complete except for missing filer contact details.
The filing documents a sale of shares that were vested as compensation and scheduled for sale the following day, which is an explicit timing fact in the notice. The form states no securities sold in the prior three months, suggesting this is a discrete transaction tied to granted compensation. However, filer identification and contact fields in the provided content are blank, which is a disclosure deficiency in the supplied document extract.
La comunicazione 猫 un Form 144 che segnala una proposta di vendita di 3,731 azioni ordinarie per un valore complessivo di $417,872. I titoli risultano in circolazione in quantit脿 di 60,658,809 azioni e la vendita proposta 猫 programmata per il 08/08/2025 sul NASDAQ.
Le azioni sono state acquisite il 08/07/2025 come restricted stock vesting dall'emittente e la contropartita 猫 indicata come compensation. Il modulo riporta "Nothing to Report" riguardo ai titoli venduti negli ultimi tre mesi. Diversi campi di contatto del dichiarante (inclusi CIK e dettagli di contatto per l'invio) risultano vuoti nel contenuto fornito.
La presentaci贸n es un Formulario 144 que informa una propuesta de venta de 3,731 acciones ordinarias por un valor agregado de $417,872. Los valores figuran como en circulaci贸n en la cantidad de 60,658,809 acciones y la venta propuesta est谩 programada para el 08/08/2025 en NASDAQ.
Las acciones se adquirieron el 08/07/2025 como restricted stock vesting del emisor y la contraprestaci贸n se registra como compensation. El formulario se帽ala "Nothing to Report" respecto a valores vendidos en los 煤ltimos tres meses. Varios campos de contacto del declarante (incluido el CIK y los detalles de contacto de la presentaci贸n) aparecen en blanco en el contenido proporcionado.
頃措嫻 鞝滌稖靹滊姅 鞝滌晥霅� 毵り皝鞚� 氤搓碃頃橂姅 Form 144搿�, 氤错喌欤� 3,731欤茧ゼ 齑濎暋 $417,872鞐� 毵り皝頃� 鞓堨爼鞛勳潉 旮办灛頃橁碃 鞛堨姷雼堧嫟. 歃濌秾鞚� 鞙犿喌 欤检嫕靾� 60,658,809欤茧 霌膘灛霅橃柎 鞛堨溂氅� 鞝滌晥霅� 毵り皝 鞚检瀽電� 08/08/2025, 瓯半灅靻岆姅 NASDAQ搿� 響滉赴霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 欤检嫕鞚� 氚滍枆靷攵�韯� 08/07/2025鞐� restricted stock vesting鞙茧 旆摑霅橃棃鞙茧┌ 雽�臧�電� compensation鞙茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞏戩嫕鞐愲姅 斓滉芳 3臧滌洈 霃欖晥 毵り皝霅� 歃濌秾鞐� 雽�頃� "Nothing to Report"搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞛� 鞐半澖觳� 頃勲摐(鞓�: CIK 氚� 鞝滌稖 鞐半澖觳� 靸侅劯)臧� 鞝滉车霅� 雮挫毄鞐愳劀 牍勳柎 鞛堧姅 頃鞚� 鞐煬 臧� 鞛堨姷雼堧嫟.
Le d茅p么t est un Formulaire 144 signalant une proposition de vente de 3,731 actions ordinaires pour une valeur globale de $417,872. Les titres sont inscrits comme en circulation 脿 hauteur de 60,658,809 actions et la vente propos茅e est pr茅vue pour le 08/08/2025 sur le NASDAQ.
Les actions ont 茅t茅 acquises le 08/07/2025 en tant que restricted stock vesting de l'茅metteur et la contrepartie est indiqu茅e comme compensation. Le formulaire note "Nothing to Report" concernant les titres vendus au cours des trois derniers mois. Plusieurs champs de contact du d茅clarant (y compris le CIK et les coordonn茅es de soumission) apparaissent vides dans le contenu fourni.
Die Einreichung ist ein Formular 144, das einen geplanten Verkauf von 3,731 Stammaktien mit einem Gesamtmarktwert von $417,872 meldet. Die Wertpapiere sind mit einer ausstehenden St眉ckzahl von 60,658,809 Aktien aufgef眉hrt, und der geplante Verkauf ist f眉r den 08/08/2025 an der NASDAQ angegeben.
Die Aktien wurden am 08/07/2025 als restricted stock vesting vom Emittenten erworben, und die Gegenleistung ist als compensation aufgef眉hrt. Das Formular vermerkt "Nothing to Report" f眉r in den letzten drei Monaten verkaufte Wertpapiere. Mehrere Kontaktfelder des Meldenden (einschlie脽lich CIK und Einreichungskontaktdaten) sind in den bereitgestellten Inhalten leer.
FAQ
What does the Form 144 report for JAZZ (metadata symbol)?
How many shares and what dollar value are scheduled for sale?
When were the shares acquired and how were they acquired?
On which exchange is the sale planned?
Were any securities sold by this person in the past three months?
